Search company, investor...


Founded Year



Series B | Alive

Total Raised


Last Raised

$15M | 16 yrs ago

About Luminetx

Luminetx Corporation discovers, develops, and commercializes bioscience technologies.

Headquarters Location

1256 Union Avenue

Memphis, Tennessee, 38104,

United States


Missing: Luminetx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Luminetx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Luminetx News

Christie Medical Innovations formerly Luminetx Corporation Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 25, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From Christie Medical Innovations formerly Luminetx Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 11:49 EST 25 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Christie Medical Innovations formerly Luminetx Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Christie Medical Innovations formerly Luminetx Corporation Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Christie Medical Innovations formerly Luminetx Corporation since January 2007. Key Findings Provides intelligence on Christie Medical Innovations formerly Luminetx Corporation MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Christie Medical Innovations formerly Luminetx Corporation and its subsidiaries since 2007. Information about key financial and legal advisors for Christie Medical Innovations formerly Luminetx Corporation's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Christie Medical Innovations formerly Luminetx Corporation's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Luminetx Frequently Asked Questions (FAQ)

  • When was Luminetx founded?

    Luminetx was founded in 2001.

  • Where is Luminetx's headquarters?

    Luminetx's headquarters is located at 1256 Union Avenue, Memphis.

  • What is Luminetx's latest funding round?

    Luminetx's latest funding round is Series B.

  • How much did Luminetx raise?

    Luminetx raised a total of $19M.

  • Who are the investors of Luminetx?

    Investors of Luminetx include Stanford Group, Morgan Keegan Ventures, Custer Capital, Diomed Holdings, Elm Ridge Capital Management and 4 more.

  • Who are Luminetx's competitors?

    Competitors of Luminetx include Novadaq Technologies, TrueVision Systems, Crescendo Bioscience, Zonare Medical Systems, TransCorp and 11 more.

Compare Luminetx to Competitors


InnerOptic is a medical device startup focused on the integration of 3D ultrasound imagery and surgery.


Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

hanse chemie GmbH

Micronics, Inc. is a developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. The Company employs a core patent estate in microfluidics -- the ability to miniaturize complex tests onto credit card size disposable devices. Per the company, tests that today take hours to days in a central laboratory environment are processed on a Micronics disposable device in seconds to minutes.


Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.

TrueVision Systems

TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.

TransCorp Logo

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.